Insight Molecular Diagnostics(IMDX)
$2.39-0.08 (-3.24%)
IMDX
Insight Molecular Diagnostics Revenue
$2.39
At close:-0.08 (-3.24%)
Want to see IMDX full AI Analyst Report?
Insight Molecular Diagnostics (IMDX) Revenue
439 Followers
Insight Molecular Diagnostics Revenue
Insight Molecular Diagnostics had a revenue of 239.00K in the quarter ending Jun 30, 2026, with 646.88%. This bring the company's revenue in the last twelve months to 1.67M, Decreased 14.32%. In the fiscal year ending Dec 31, 2025, Insight Molecular Diagnostics had annual revenue of 4.05M with 115.58% growth.
- Revenue (ttm)
- 1.67M
- Revenue Growth
- -60.77%
- P/S Ratio
- 19.93
- Revenue/Employee
- $71,140
- Employees
- 57
- Market Cap
- $80.83M
Revenue Chart
Insight Molecular Diagnostics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.05M | 2.17M | 115.58% |
| Dec 31, 2024 | 1.88M | 378.00K | 25.15% |
| Mar 31, 2024 | 1.50M | 545.00K | 56.89% |
| Mar 31, 2023 | 958.00K | -1.24M | -56.41% |
| Dec 31, 2021 | 2.20M | 982.00K | 80.76% |
| Dec 31, 2020 | 1.22M | 1.22M | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Mar 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.